Rangeley Capital’s Kiora Pharmaceuticals KPRX Stock Holding History

Rangeley Capital’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$19.3K	–	195
2026 Q1	$19.3K	Buy	+10,000	New	+$21.1K	0.02%	136

Other funds holding KPRX

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

Rangeley Capital's KPRX Position: Q2 2026 in Review

Rangeley Capital sold out of Kiora Pharmaceuticals (KPRX) in Q2 2026, closing a stake of 10,000 shares — an estimated $19.3K sold.

Rangeley Capital first reported a position in KPRX in Q1 2026 and held it in 1 quarter. The position peaked at $19.3K in Q1 2026. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

Rangeley Capital reported no remaining Kiora Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Rangeley Capital sold 10,000 Kiora Pharmaceuticals shares in Q2 2026, an estimated $19.3K.
Rangeley Capital first reported a position in Kiora Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Rangeley Capital's Kiora Pharmaceuticals position peaked at $19.3K in Q1 2026.
22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.